Announces Capital Markets Advisory Agreement VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina Therapeutics” or the “Company”), a biopharmaceutical company dedicated to improving
Announces Capital Markets Advisory Agreement Read More
Related
Share this page
Guest Posts by Easy Branches